Source BioScience writes...this month – February 2023 – we welcomed the launch of our new facility in Cambridge, showcasing the expansion of our state-of-the-art laboratories for genomics and precision medicine.
With genomic medicine and precision therapeutics being at the heart of bioscience developments, we are thrilled to level-up our contributions to the field and strengthen our ability to partner with life science academia, pharmaceutical and biotechnology organisations in reaching their research goals.
The expansion of this laboratory space mirrors our commitment to providing market-leading genomic and precision medicine services; fuelling the growth of genomic advancements as they evolve.
After the successful launch of our new genomics and precision medicine facility in Cambridge, read the media coverage here.
Image Credit: Source BioScience / Leo Hillier for the photography.
L – R: Klaudyna Johnstone (Marketing Director), Dave Negus (Group Sequencing Manager), Richard Stevens (Director of Genomics), Jay LeCoque ( Chairman and CEO) and Tony Ratcliffe (Chief Financial Officer)
